Eversana reaches predictive intelligence agreement


Partners with ArisGlobal to improve the patient support and pharmacovigilance experience

Eversana, a provider of global commercial services to the life sciences industry, and ArisGlobal, a drug development software company, have officially reached a partnership that Eversana says will “digitally transform end-to-end pharmacovigilance services, leading to safer, more effective healthcare for patients worldwide.”

Per the agreement, Eversana will use ArisGlobal's LifeSphere cloud platform for clinical and commercial product safety management, which includes intelligent automation and machine-learning-enhanced adverse event case processing—the commercial services company began onboarding clients to the platform last month and plans to continuing doing so into next year.

The technology adds real-time predictive intelligence to Eversana's drug safety repertoire, including the capability to process and analyze data to recommend appropriate products to patients. It will also help clients determine safe options when it comes to therapeutics.

This latest announcement comes after Eversana reached data deals with both Symphony Health and Compile back in November.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.